Eagle Genomics Secures Industrial Strategy Challenge Fund Grant to Develop Pioneering Life Sciences Data Curation Module
Smart data management for life sciences company, Eagle Genomics, has today announced it has been awarded a close to £600,000 grant from Innovate UK, the UK’s innovation agency, to support the company’s ongoing commitment to radically reduce time to insight through data science.
The project which has received the grant, under the banner; ‘Increase your data's value: A value-driven semantic enrichment system to speed up scientific insight’ – will further develop the pioneering e [curate] data curation module. Using a unique combination of conversational and statistical learning, decision theory and semantic enrichment, e [curate] will enable scientists to question data with context, significantly improving relevancy and, therefore, speed to insight. Integrated as part of Eagle’s ‘e[ automateddata scientist] ’ platform, e [curate] will solve the constraints scientists currently experience in being able to weave and store data consistently.
In support of the project Eagle Genomics will receive a share of the £197m to be invested in healthcare and medicine through the Industrial Strategy Challenge Fund, introduced by the UK Government to help meet the ‘major industrial and societal challenges of our time’.
The impact of the e [curate] platform on life sciences research will be significant, not only in addressing the challenge of speeding up patient access to new drugs and treatments, but also in reducing the cost of bringing drugs to market.
Executive Chairman at Eagle Genomics, Anthony Finbow commented - “We are delighted to have received this Innovate UK award, in recognition of the potential of our platform to radically reduce the time and cost involved in achieving scientific insight. We’re excited about the impact this will have on drug discovery and innovation, resulting in better tailored therapeutics (precision medicines) and safer consumer products.”
The Chief Executive of the UK’s innovation agency, Innovate UK, Dr Ruth McKernan commented: “Innovate UK is proud to support Eagle Genomics in the development of the e [curate] platform which has the potential to accelerate scientific discovery, through intelligent data storage and analysis. This will speed the creation of new medicines, increasing productivity in the health and life sciences, a key aim of the Industrial Strategy Challenge Fund.”
About Eagle Genomics
Eagle Genomics is a smart data management software company helping life sciences companies conducting data intensive research to bring new candidate medicines, therapies and products to patients and customers more quickly. Its e[ automateddata scientist] platform puts state of the industry data science at the fingertips of biologists to radically reduce time to cost of research, thus enabling customers to achieve drastic productivity improvements and true data driven discovery.
For more information on Eagle Genomics, please visit the company’s website, follow Eagle Genomics on Twitter (@Eaglegen ) or call Eagle Genomics at +44 (0)1223 654481
About Innovate UK
Innovate UK is the UK's innovation agency. It works with people, companies and partner organizations to find and drive the science and technology innovations that will grow the UK economy.
For further information visit www.innovateuk.gov.uk .
UK +44 7719 622303
USA +1 914 215 4345
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
CA-TRADESHIFT19.10.2018 13:02 | pressemeddelelse
Tradeshift Announces Q3 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum